Table 2. Risks predicted by the PHLF risk score of Hokkaido University and AMC/MSKCC.
| Group | Total points | Hokkaido University | AMC/MSKCC | |||||
|---|---|---|---|---|---|---|---|---|
| Number of patients/PHLF | Predicted risk of PHLF (%) | Observed PHLF rate (%) | Number of patients (%) | Predicted risk of PHLF (%) | Observed PHLF rate (%) | |||
| Low risk | 0 | 40/6 | 4 | 13.7 | 34 | 4 | 5 | |
| 1 | 11/1 | 10 | 7 | |||||
| Intermediate risk | 2 | 81/17 | 14 | 24.5 | 44 | 12 | 14 | |
| 3 | 29/10 | 20 | 20 | |||||
| High risk | 4 | 65/22 | 44 | 39.8 | 53 | 33 | 44 | |
| 5 | 27/14 | 18 | 48 | |||||
| 6 | 1/1 | 11 | 64 | |||||
| 7 | 0 | 1 | 67 | |||||
| 8 | 0 | 7 | 87 | |||||
PHLF, post-hepatectomy liver failure; AMC/MSKCC, Academic Medical Centre/Memorial Sloan Kettering Cancer Center.